Reports for ALLERGAN INC
Company Name
ALLERGAN INC
Totals |
||
Shortage reports |
39 |
|
| Actual shortage: | 3 (8%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 36 (92%) | |
Discontinuation Reports |
25 |
|
| To be discontinued: | 1 (4%) | |
| Discontinued: | 22 (88%) | |
| Reversed: | 2 (8%) | |
Late reports |
17 (27%) |
|
Overdue reports |
3 (75%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TAZORAC | 0.1% | GEL | Discontinued | 2023-09-15 | 2023-10-01 | 204561 |
| TAZORAC | 0.05% | CREAM | Discontinued | 2023-09-15 | 2023-12-01 | 204564 |
| TAZORAC | 0.1% | CREAM | Discontinued | 2021-11-26 | 2022-03-14 | 150061 |
| VIBERZI | 75MG | TABLET | Reversed | 2022-03-23 | 2022-06-29 | 157156 |
| VIBERZI | 100MG | TABLET | Reversed | 2022-03-23 | 2022-06-22 | 157159 |